Skip to main content

Table 2 Duration of follow up and incidence of MACE in patients with and without ISMN

From: Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention

  All (n = 108 ) Without ISMN (n = 62) With ISMN (n = 46 ) P value
Duration of Follow-up (months) 25.3 ± 25 26.2 ± 10.8 24.1 ± 13.5 0.39
MACE, n (%) 16 (14.8) 4 (6.5) 12 (26.1) * < 0.01
Cardiovascular mortality, n (%) 3 (2.8) 2 (3.2) 1 (2.2) 1.00
Non-fatal myocardial infarction, n (%) 6 (5.5) 0 (0) 6 (13.0) * < 0.01
In-stent restenosis, n (%) 7 (6.5) 2 (3.2) 5 (10.9) 0.13
All cause mortality, n (%) 5 (4.6) 3 (4.8) 2 (4.3) 1.00
  1. Abbreviation: Similar to Table 1, MACE: Major adverse cardiovascular events.